We’re excited to see everyone at ARVO 2025 in Salt Lake City in May! We love ARVO…the incredible presentations and posters that highlight breakthrough research from our community, the opportunity to get out an about in new places and of course see all of you! Feel free to bookmark this list for use before, during
23.04
2024
Phoenix-Micron Enhances OCT Imaging with AI-powered OCT Segmentation
Phoenix-Micron, Inc. and ArtiKode Intelligence Collaborate to Bring Automated, AI-Powered OCT Segmentation to MICRON Software Suite Bend, OR, USA – April 23, 2024 – Phoenix-Micron, Inc. (“Phoenix”), recognized globally for its leadership in in vivo ophthalmic imaging of small animals, today announced a collaboration with ArtiKode Intelligence (“ArtiKode”), a Valencia, Spain-based innovator in artificial intelligence (AI)
08.04
2024
MICRON Imaging Systems: Powering 900 Scientific Publications
The ability to see the world around us is a gift that’s easy to take for granted, until it’s threatened by the onset of a devastating eye disease. For those facing the reality of vision loss, ophthalmic research represents a beacon of hope, offering the promise of new treatments and therapies to preserve or restore
28.03
2024
Your Guide to Navigating Seattle for ARVO 2024
We’re excited to see everyone at ARVO 2024 in Seattle in May! Every year, we are impressed and humbled by the incredible presentations and posters that highlight breakthrough research related to new disease models, diagnostics, and therapies. Phoenix-Micron is headquartered in the Northwest, and many of our team members are either from the Seattle area
16.08
2023
Small zebrafish are impressive, effective models for studying endotoxin induced uveitis
Researchers at Henan Province Eye Hospital in China have made great strides in studying endotoxin-induced uveitis (EIU) by creating a novel EIU model in zebrafish. Uveitis is an ocular inflammation and one of the main causes of visual impairment, accounting for 10-15% of global blindness. Mice have typically been the research animal of choice however
11.07
2023
Researchers find early signs of Alzheimer’s disease (AD) in the mouse retina and develop a non-invasive artificial intelligence-based system that could be used to diagnose the disease before the appearance of clinical symptoms
Progress in diagnosing and treating Alzheimer’s disease (AD) has been accelerating over the last few years. Until now, AD has been difficult to diagnose. The disease can be present years before distinguishable symptoms manifest. Non-invasive diagnostic tests have been lacking, and diagnosis often relies on memory, cognitive, and behavioral tests. In 2011, Koronyo-Hamaoui M, Koronyo